Search research articles
Contact Us
Filters
Showing results (371-380 of 391) with videos related to
Page
of 40
Sort By:
Disability and Health Journal
|
December 9, 2023
Disability and COVID-19: Challenges, testing, vaccination, and postponement and avoidance of medical care among minoritized communities
Haley R Martin, Nan Hu, Qingyun Liu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 5, 2021
Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial
Robin K Avery, Sophie Alain, Barbara D Alexander, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1997
Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy
P Rougier, R Bugat, J Y Douillard, et al.
Arthritis Care & Research
|
October 20, 2019
Development of a Set of Lupus-Specific, Ambulatory Care-Sensitive, Potentially Preventable Adverse Conditions: A Delphi Consensus Study
Candace H Feldman, Cameron Speyer, Rachel Ashby, et al.
Mycoses
|
February 6, 2019
Outcomes of patients with invasive fusariosis who undergo further immunosuppressive treatments, is there a role for secondary prophylaxis?
Marcio Nucci, Shmuel Shoham, Edson Abdala, et al.
The Journal of Antimicrobial Chemotherapy
|
September 11, 2021
When to change treatment of acute invasive aspergillosis: an expert viewpoint
Monica A Slavin, Yee-Chun Chen, Catherine Cordonnier, et al.
Blood Advances
|
May 7, 2020
BK virus-specific T-cell immune reconstitution after allogeneic hematopoietic cell transplantation
Eduardo Espada, Matthew P Cheng, Haesook T Kim, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 10, 2020
A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Lower Respiratory Tract
Francisco M Marty, Roy F Chemaly, Kathleen M Mullane, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 27, 2015
Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors
Jo-Anne H Young, Brent R Logan, Juan Wu, et al.
The New England Journal of Medicine
|
December 30, 2011
Three patients with full facial transplantation
Bohdan Pomahac, Julian Pribaz, Elof Eriksson, et al.
Page
of 40
Search research articles
Search
Showing results (371-380 of 391) with videos related to
Sort By:
Page
of 40
Disability and Health Journal
|
December 9, 2023
Disability and COVID-19: Challenges, testing, vaccination, and postponement and avoidance of medical care among minoritized communities
Haley R Martin, Nan Hu, Qingyun Liu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 5, 2021
Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial
Robin K Avery, Sophie Alain, Barbara D Alexander, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1997
Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy
P Rougier, R Bugat, J Y Douillard, et al.
Arthritis Care & Research
|
October 20, 2019
Development of a Set of Lupus-Specific, Ambulatory Care-Sensitive, Potentially Preventable Adverse Conditions: A Delphi Consensus Study
Candace H Feldman, Cameron Speyer, Rachel Ashby, et al.
Mycoses
|
February 6, 2019
Outcomes of patients with invasive fusariosis who undergo further immunosuppressive treatments, is there a role for secondary prophylaxis?
Marcio Nucci, Shmuel Shoham, Edson Abdala, et al.
The Journal of Antimicrobial Chemotherapy
|
September 11, 2021
When to change treatment of acute invasive aspergillosis: an expert viewpoint
Monica A Slavin, Yee-Chun Chen, Catherine Cordonnier, et al.
Blood Advances
|
May 7, 2020
BK virus-specific T-cell immune reconstitution after allogeneic hematopoietic cell transplantation
Eduardo Espada, Matthew P Cheng, Haesook T Kim, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 10, 2020
A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Lower Respiratory Tract
Francisco M Marty, Roy F Chemaly, Kathleen M Mullane, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 27, 2015
Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors
Jo-Anne H Young, Brent R Logan, Juan Wu, et al.
The New England Journal of Medicine
|
December 30, 2011
Three patients with full facial transplantation
Bohdan Pomahac, Julian Pribaz, Elof Eriksson, et al.
Page
of 40